Aspire Pharmaceuticals, Inc.
FEI 3003159106 · 37 & 41 Veronica Ave, Somerset, New Jersey, 08873-6800, United States
1 warning letter on record
Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports
Get a dated evidence report for this supplierFree · for your supplier file · sample
Import alerts
0
Import refusals (5 years)
0
Warning letters
1
Last FDA action
2023-07-14
3 years ago
FDA record
- 2022-11-23Warning letterFDA Warning Letter (CFSAN)FDA source